FDA rejects higher-dose SPINRAZA application due to manufacturing (CMC) deficiencies.

{
  "signal_id": "a5e6513c-116d-462c-870d-a052abfb3374",
  "signal_type": "sec-10k",
  "signal_subtype": "complianceBurden",
  "detected_at": "2026-02-10T07:50:47.777+00:00",
  "company": {
    "name": "Biogen",
    "domain": "biogen.com"
  },
  "data": {
    "detail": "The FDA issued a Complete Response Letter (CRL) for a higher dose of SPINRAZA, citing issues with Chemistry, Manufacturing, and Controls (CMC) data. This regulatory setback delays revenue and creates an urgent need to address technical documentation and manufacturing processes, opening opportunities for regulatory consultants and quality management solution providers.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "FDA rejects higher-dose SPINRAZA application due to manufacturing (CMC) deficiencies.",
    "excerpts": "In September 2025 the FDA issued a CRL for the supplemental NDA for a higher dose regimen of nusinersen for the treatment of SMA.",
    "relevance": 0.8,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000013/biib-20251231.htm",
    "filing_date": "2026-02-06",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "GRC tools needed",
    "signal_category": "risk",
    "regions_mentioned": [
      "U.S."
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/a5e6513c-116d-462c-870d-a052abfb3374 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"biogen.com","limit":20}'